The E14 Fund

E14 Fund is an MIT-affiliated venture capital firm focused on supporting deep-tech startups emerging from the MIT community. Established in 2013 and rooted in the MIT Media Lab, the fund specializes in companies that are addressing critical global challenges through breakthrough science and engineering. E14 Fund invests in early-stage startups, typically from pre-seed to Series A, with a focus on industries such as robotics, artificial intelligence, quantum computing, and synthetic biology. Some notable investments include Formlabs, a leader in 3D printing technology, and Overjet, a pioneer in AI-powered dental care solutions. The fund is more than just a capital provider; it acts as a strategic partner, helping founders transition from academic research to building scalable businesses. E14 leverages the vast MIT network to connect entrepreneurs with industry leaders, mentors, and technical resources that can help accelerate their growth. A significant portion of the firm’s profits is reinvested into MIT, highlighting its commitment to fostering long-term innovation within the university ecosystem. Led by managing partners Calvin Chin and Habib Haddad, E14 Fund works closely with founders to address both scientific and business challenges, providing hands-on support throughout their journey. The fund’s portfolio companies typically possess unique intellectual property and a clear path to market dominance, reflecting E14’s focus on ventures with transformative potential. By supporting startups from their earliest stages, E14 Fund plays a crucial role in translating groundbreaking MIT research into impactful, market-ready technologies.